You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
Supporting Documentation
Product Specifications
Product Code |
Description |
---|---|
DHVM12 | DERMABOND MINI TOPICAL SKIN ADHESIVE - 2-OCTYLCYANOACRYLATE HIGH VISCOSITY FORMULATION FOR SMALL INCISIONS AND LACERATIONS; 0.36ML ADHESIVE VOLUME |
References
*S. epidermidis, E. coli, S. aureus, P. aeruginosa, E. faecium.
† Clinical significance unknown.
1. Quinn J, Wells G, Sutclie T, et al. A randomized trial comparing octylcyanoacrylate tissue adhesive and sutures in the management of lacerations. JAMA. 1997;277:1527-1530.
2. Bhende S, Rothenburger S, Spangler DJ, Dito M. In vitro assessment of microbial barrier properties of DERMABOND® Topical Skin Adhesive. Surg Infect. 2002;3(3):251-257.
3. In vitro evaluation of the viability of microorganisms after direct contact with DERMABOND® Topical Skin Adhesive. 2010
4. Clinical significance unknown.
For complete indications, contraindications, warnings, precautions, and adverse reactions, please reference full package insert.
© Ethicon US, LLC. 2019.
For complete indications, contraindications, warnings, precautions, and adverse reactions, please reference full package insert.
This site is published by Ethicon US, LLC, which is solely responsible for its contents, and is intended for U.S. audiences only.
This site is intended for Healthcare Professionals. If you are a patient, it is important that you discuss information about the benefits and risks of products with your doctor.
Last updated February 20, 2019. The third-party trademarks used herein are trademarks of their respective owners. Data and usage fees may apply. See your carrier for more information.